TGLVY
Price
$0.60
Change
-$0.01 (-1.64%)
Updated
Aug 15 closing price
Capitalization
1.18B
TRUMY
Price
$18.67
Change
+$0.07 (+0.38%)
Updated
Aug 15 closing price
Capitalization
27.57B
81 days until earnings call
Interact to see
Advertisement

TGLVY vs TRUMY

Header iconTGLVY vs TRUMY Comparison
Open Charts TGLVY vs TRUMYBanner chart's image
Top Glove
Price$0.60
Change-$0.01 (-1.64%)
Volume$900
Capitalization1.18B
Terumo
Price$18.67
Change+$0.07 (+0.38%)
Volume$48.29K
Capitalization27.57B
TGLVY vs TRUMY Comparison Chart in %
Loading...
TGLVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRUMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TGLVY vs. TRUMY commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TGLVY is a Hold and TRUMY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (TGLVY: $0.60 vs. TRUMY: $18.67)
Brand notoriety: TGLVY and TRUMY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: TGLVY: 121% vs. TRUMY: 32%
Market capitalization -- TGLVY: $1.18B vs. TRUMY: $27.57B
TGLVY [@Pharmaceuticals: Other] is valued at $1.18B. TRUMY’s [@Pharmaceuticals: Other] market capitalization is $27.57B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $172.16B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TGLVY’s FA Score shows that 1 FA rating(s) are green whileTRUMY’s FA Score has 0 green FA rating(s).

  • TGLVY’s FA Score: 1 green, 4 red.
  • TRUMY’s FA Score: 0 green, 5 red.
According to our system of comparison, TRUMY is a better buy in the long-term than TGLVY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TGLVY’s TA Score shows that 5 TA indicator(s) are bullish while TRUMY’s TA Score has 5 bullish TA indicator(s).

  • TGLVY’s TA Score: 5 bullish, 2 bearish.
  • TRUMY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TGLVY is a better buy in the short-term than TRUMY.

Price Growth

TGLVY (@Pharmaceuticals: Other) experienced а -6.88% price change this week, while TRUMY (@Pharmaceuticals: Other) price change was +0.38% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.19%. For the same industry, the average monthly price growth was -0.65%, and the average quarterly price growth was +3.82%.

Reported Earning Dates

TRUMY is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.19% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRUMY($27.6B) has a higher market cap than TGLVY($1.18B). TGLVY has higher P/E ratio than TRUMY: TGLVY (79.33) vs TRUMY (34.78). TRUMY YTD gains are higher at: -4.256 vs. TGLVY (-47.105). TRUMY has higher annual earnings (EBITDA): 247B vs. TGLVY (426M). TRUMY has more cash in the bank: 195B vs. TGLVY (528M). TGLVY has less debt than TRUMY: TGLVY (1.01B) vs TRUMY (175B). TRUMY has higher revenues than TGLVY: TRUMY (987B) vs TGLVY (3.43B).
TGLVYTRUMYTGLVY / TRUMY
Capitalization1.18B27.6B4%
EBITDA426M247B0%
Gain YTD-47.105-4.2561,107%
P/E Ratio79.3334.78228%
Revenue3.43B987B0%
Total Cash528M195B0%
Total Debt1.01B175B1%
FUNDAMENTALS RATINGS
TGLVY vs TRUMY: Fundamental Ratings
TGLVY
TRUMY
OUTLOOK RATING
1..100
8619
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
36
Fair valued
PROFIT vs RISK RATING
1..100
10093
SMR RATING
1..100
9199
PRICE GROWTH RATING
1..100
8750
P/E GROWTH RATING
1..100
6245
SEASONALITY SCORE
1..100
n/a32

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TGLVY's Valuation (28) in the null industry is in the same range as TRUMY (36). This means that TGLVY’s stock grew similarly to TRUMY’s over the last 12 months.

TRUMY's Profit vs Risk Rating (93) in the null industry is in the same range as TGLVY (100). This means that TRUMY’s stock grew similarly to TGLVY’s over the last 12 months.

TGLVY's SMR Rating (91) in the null industry is in the same range as TRUMY (99). This means that TGLVY’s stock grew similarly to TRUMY’s over the last 12 months.

TRUMY's Price Growth Rating (50) in the null industry is somewhat better than the same rating for TGLVY (87). This means that TRUMY’s stock grew somewhat faster than TGLVY’s over the last 12 months.

TRUMY's P/E Growth Rating (45) in the null industry is in the same range as TGLVY (62). This means that TRUMY’s stock grew similarly to TGLVY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TGLVYTRUMY
RSI
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
64%
Momentum
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
73%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
55%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
66%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
65%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
67%
Declines
ODDS (%)
Bearish Trend 24 days ago
85%
Bearish Trend 7 days ago
65%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
71%
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
TGLVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRUMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARWR20.511.73
+9.21%
Arrowhead Pharmaceuticals
AVTX9.020.07
+0.78%
Avalo Therapeutics
BAP251.881.52
+0.61%
Credicorp Ltd
MYE16.12-0.30
-1.83%
Myers Industries
CARV1.80-0.05
-2.63%
Carver Bancorp

TGLVY and

Correlation & Price change

A.I.dvisor tells us that TGLVY and DCTH have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TGLVY and DCTH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGLVY
1D Price
Change %
TGLVY100%
-1.72%
DCTH - TGLVY
21%
Poorly correlated
-1.05%
TPGVF - TGLVY
8%
Poorly correlated
N/A
TRUMY - TGLVY
5%
Poorly correlated
+0.38%
VYCO - TGLVY
4%
Poorly correlated
N/A
UEEC - TGLVY
3%
Poorly correlated
+8.99%
More

TRUMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRUMY has been loosely correlated with HOCPY. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TRUMY jumps, then HOCPY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRUMY
1D Price
Change %
TRUMY100%
+0.38%
HOCPY - TRUMY
51%
Loosely correlated
+1.01%
SSMXY - TRUMY
46%
Loosely correlated
+1.04%
OLYMY - TRUMY
44%
Loosely correlated
-1.00%
GNNDY - TRUMY
33%
Poorly correlated
+2.74%
ESLOY - TRUMY
30%
Poorly correlated
+1.92%
More